These findings suggest that, within strictly defined CKM syndrome stage 2 populations, the renoprotective effects of statin therapy did not reach statistical significance during the study periods examined.
← all excerpts
Effect of statin therapy on renal and lipid outcomes in CKM syndrome stage 2: a meta-analysis of randomized controlled trials.
1
—
—